Hank Azaria (“Brockmire,” “Ray Donovan”), Haneefah Wood (“Truth Be Told,” “One Day at a Time”), Alison Pill (“Them,” “The Newsroom”), Nick Podany (“Harry Potter And The Cursed Child” on Broadway) and Dewshane Williams (“The Umbrella Academy,” “In the Dark”), are set to star alongside Billy Crudup in the Apple TV+ original series “Hello Tomorrow!,” from MRC Television, reports Deadline.
About ‘Hello, Tomorrow!’
“Hello Tomorrow!,” a new, 10-episode half-hour dramedy that will star Emmy and Critics Choice Award winner Crudup (“The Morning Show”) who will also serve as an executive producer. Jonathan Entwistle (“The End of the F***ing World”) is attached to direct the series, which hails from MRC Television.
Here’s how the series is described: Set in a retro-future world, “Hello Tomorrow!” centers around a group of traveling salesmen hawking lunar timeshares. Crudup stars as Jack, a salesman of great talent and ambition, whose unshakeable faith in a brighter tomorrow inspires his coworkers, revitalizes his desperate customers but threatens to leave him dangerously lost in the very dream that sustains him.
“Hello Tomorrow!” is written and created by Amit Bhalla and Lucas Jansen (“Bloodline,” “The Money”). Entwistle, Bhalla, Jansen will also serve as executive producers alongside Crudup. Blake Griffin, Ryan Kalil and Noah Weinstein will executive produce through their banner Mortal Media.
About Apple TV+
Apple TV+ is available on the Apple TV app in over 100 countries and regions, on over 1 billion screens, including iPhone, iPad, Apple TV, Mac, popular smart TVs from Samsung, LG, Sony, VIZIO, TCL and others, Roku and Amazon Fire TV devices, Chromecast with Google TV, PlayStation and Xbox gaming consoles, and at tv.apple.com, for $4.99 per month with a seven-day free trial. For a limited time, customers who purchase and activate a new iPhone, iPad, Apple TV, Mac or iPod touch can enjoy three months of Apple TV+ for free.*
For more information, visit apple.com/tvpr and see the full list of supported devices.
12 Comments
Comments are closed.